Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...
975 Views
Alliance Healthcare, Leveraging on Digital Health Trends, Debuts on SGX
Alliance Healthcare Group, an integrated healthcare group, listed on SGX Catalist today. The Group leverages the use of technology to provide a...
61 Views
Healthcare Sector’s Growth Prospects Draw Fund Flows
Singapore’s healthcare sector is typically viewed as defensive and poised to enjoy multi-year growth prospects. Between July and Dec 2018, the...
49 Views
Thomson Medical – Limited Impact from Proposed Distribution of RE Business. Still Looks Expensive.
Thomson Medical Group f.k.a. Rowsley Ltd (ROWS SP) (“TMG”), a SGX-listed healthcare and property developer, announced this morning that it plans to...
360 Views
Qualitas Medical Group IPO Review - Valuation up 95% in One Month
Qualitas Medical Group (QMGL SP) is looking to raise approximately US$102m in its upcoming IPO. The company will be using the proceeds to make...
516 Views